Latest News Releases From The Newsroom
Raytheon Secures $887.93M Contract Modification; BofA Securities Bullish on Carnival and Palantir
June 12th, 2023
Pratt and Whitney Military Engines, a Raytheon Technologies (NYSE: RTX) business, has been awarded a significant modification to a contract for the procurement of F-135 propulsion system spare parts and support equipment. The firm-fixed-pric. Read more
SEC Charges Investment Adviser and Principal in Abusive Naked Short Selling Scheme
June 12th, 2023
FOR IMMEDIATE RELEASE 2023-107 Washington D.C. / CRWE PRESS RELEASE / June 12, 2023 — The Securities and Exchange Commission today charged investment adviser Sabby Management LLC and its managing partner, Hal D. Mintz, with fraud in c. Read more
Triple Impact: iBio's Collaboration, Oracle's Strong Q4, and EVgo's Charging Network Growth Make Waves
June 12th, 2023
iBio, Inc. (NYSE American: IBIO) has partnered with the National Institute of Allergy and Infectious Diseases (NIAID) to explore the potential of the company's AI-driven epitope steering platform in developing a vaccine for Lassa fever, a severe and . Read more
Nasdaq Is To Takeover Adenza, Catalent Reports Q3 Loss: Market Updates
June 12th, 2023
Nasdaq, Inc. (Nasdaq: NDAQ) has announced a definitive agreement to acquire Adenza, a leading provider of risk management and regulatory software to the financial services industry, from Thoma Bravo for a total consideration of $10.5 billion in cash . Read more
Alvotech, Teva, JNJ Settle on AVT04; Teck Resources Evaluating Glencore Proposal
June 12th, 2023
Alvotech (Nasdaq: ALVO) and an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have announced a settlement and license agreement with Johnson & Johnson (NYSE: JNJ) concerning AVT04, Alvotech's proposed biosimilar to Stelara (ustekinumab. Read more
Keybanc Sees Opportunity On AMD, AppFolio, AvidXchange, and Ameren
June 12th, 2023
Advanced Micro Devices, Inc. (Nasdaq: AMD), a leading semiconductor company specializing in advanced computing and graphics technologies, saw its price target raised by KeyBanc from $110 to $150. With $AMD closing at $124.92 on Friday, this . Read more
Pharvaris: Potential On-Demand HAE Treatment; Novartis Is To Takeover Chinook Therapeutics
June 12th, 2023
Pharvaris N.V. (Nasdaq: PHVS) released data from their Phase 2 study, RAPIDe-1, evaluating the on-demand treatment of hereditary angioedema (HAE) attacks with PHVS416 (deucrictibant immediate-release capsules). The study showed that treatment with. Read more
Intellia Therapeutics and Ocular Therapeutix: Promising Trial Data for HAE and Wet AMD
June 11th, 2023
Intellia Therapeutics, Inc. (Nasdaq: NTLA) has shared updated interim results from the Phase 1 portion of their ongoing study of NTLA-2002, a CRISPR candidate for treating hereditary angioedema (HAE). The company believes that the data reinf. Read more
Quarterly Results Ahead: Adobe, Kroger, Jabil, and Cognyte Reports Coming
June 10th, 2023
Thursday, June 15, will see several companies releasing their financial results, including: Adobe Inc. (Nasdaq: ADBE), a global leader in digital media and marketing solutions, is set to announce its second-quarter fiscal year 2023 results after t. Read more
Earnings Figures Preview: Lennar, Anterix, Aurora Cannabis, and High Tide
June 10th, 2023
Several companies are expected to report their financial results on Wednesday, June 14, including: Lennar Corporation (NYSE: LEN)(NYSE:LEN.B), a leading home construction and real estate development company, is set to announce its second-qua. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025




Member Login